FindTrial
Sign In

Viral Excretion Among COVID-19 Omicron Recurrence Patients

Viral Excretion and Its Influencing Factors Among COVID-19 Omicron Recurrence Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05470426
Enrollment
35
Registered
2022-07-22
Start date
2022-07-31
Completion date
2023-08-31
Last updated
2022-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 Recurrence, Surface Contamination

Brief summary

The study analyzes the viral nucleic acid excretion and its influencing factors of SARS-COV-2 Omicron recurrence patients.

Interventions

OTHERCOVID-19 Omicron Recurrence

COVID-19 Omicron Recurrence

Sponsors

RenJi Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients with nucleic acid detection N gene and ORF gene Ct value \< 40 after discharge from hospital * Being able to provide basic information, living habits, vaccination information, admission information

Exclusion criteria

* Single gene target positive * Patients with incomplete baseline data

Design outcomes

Primary

MeasureTime frameDescription
COVID-19 Omicron RecurrenceSix monthsCOVID-19 Omicron Recurrence

Countries

China

Contacts

Primary ContactYa Yang, PhD
yangya@renji.com68383362

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026